XML 70 R53.htm IDEA: XBRL DOCUMENT

Quarterly Results of Operations (unaudited) (Tables)

12 Months Ended

Dec. 31, 2022

Quarterly Financial Data [Abstract]

Unaudited consolidated quarterly results of operations

The unaudited consolidated quarterly results of operations (in thousands, except per share data) were as follows:


			For the Three Months Ended
			December 31						September 30						June 30						March 31
2022
Total revenue			$	382,432					$	352,585					$	319,939					$	297,057
Total operating expenses			384,310						339,634						324,572						299,855
Net income (loss) from continuing operations			(11,349)						2,123						(4,125)						(5,350)
Net loss from discontinued operations, net of tax			—						—						(463)						—
Net income (loss) attributable to common shareholders of Evolent Health, Inc.			(11,349)						2,123						(4,588)						(5,350)

Income (loss) per common share
Basic and diluted


			For the Three Months Ended
			December 31						September 30						June 30						March 31
Continuing operations			$	(0.11)					$	0.02					$	(0.05)					$	(0.06)
Discontinued operations			—						—						—						—

2021
Total revenue			$	248,358					$	222,471					$	222,057					$	215,071
Total operating expenses			260,572						229,052						229,728						231,016
Net income (loss) from continuing operations			3,053						(13,040)						(9,107)						(11,190)
Net income (loss) from discontinued operations, net of tax			(8,700)						—						—						1,383
Net loss attributable to common shareholders of Evolent Health, Inc.			(5,647)						(13,040)						(9,107)						(9,807)

Income (loss) per common share
Basic and diluted
Continuing operations			$	0.03					$	(0.15)					$	(0.11)					$	(0.13)
Discontinued operations			(0.09)						—						—						0.01